Skip to main content
NXGL
NASDAQ Life Sciences

NEXGEL Ousts CEO, Launches Strategic Review Amid Going Concern Crisis

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.387
Mkt Cap
$4.776M
52W Low
$0.3
52W High
$2.89
52W Position info
29% above low
Off High info
87% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

NXGL sits 29% above its 52-week low of $0.3.

Summary

NEXGEL replaced CEO Adam Levy with Brian Kieser effective August 21, 2026, and formed a Special Committee to review strategic alternatives, capital structure, and liquidity. This follows a going concern warning in the Q2 10-Q, potential defaults on $13.9M in convertible notes, material weaknesses in internal controls, and a rejected share increase proposal. The board is signaling a potential restructuring or asset divestiture, with the committee expected to present a framework within 30-45 days. The company's market cap is under $5 million, making this a high-stakes turnaround attempt. Watch for the committee's recommendations and any update on the reverse stock split proposal filed August 14.

At the time of this announcement, NXGL was trading at $0.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.8M. The 52-week trading range was $0.30 to $2.89. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

NXGL - Latest Insights

NXGL
Nov 18, 2026, 5:24 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.50
Real-time Price: $3.07 info
Change: -$0.430 (-12%) info
Market Cap: $9.741M info
NXGL
Nov 13, 2026, 9:59 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $3.87
Real-time Price: $3.07 info
Change: -$0.800 (-21%) info
Market Cap: $9.741M info
NXGL
Nov 13, 2026, 9:20 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.39
Real-time Price: $3.07 info
Change: -$0.320 (-9%) info
Market Cap: $9.741M info
NXGL
Nov 12, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.40
Real-time Price: $3.07 info
Change: -$1.33 (-30%) info
Market Cap: $9.741M info
NXGL
Nov 11, 2026, 9:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.58
Real-time Price: $3.07 info
Change: -$0.510 (-14%) info
Market Cap: $9.741M info